NCT03539406 Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients Status COMPLETED Phase PHASE1
NCT03532204 Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer Status WITHDRAWN Phase NA
NCT03524391 Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients Status COMPLETED Phase NA
NCT03523234 Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage Status UNKNOWN Phase NA
NCT03521245 Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer Status UNKNOWN Phase N/A
NCT03512197 A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT03494946 Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer Status RECRUITING Phase NA
NCT03491033 Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy Status COMPLETED Phase N/A
NCT03417037 An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT03410693 Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT03399253 Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor Status RECRUITING Phase PHASE2/PHASE3
NCT03393741 Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy Status TERMINATED Phase N/A
NCT03386162 SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer Status TERMINATED Phase PHASE2
NCT03353831 Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer Status COMPLETED Phase PHASE3
NCT03353675 A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT03351361 Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients Status COMPLETED Phase PHASE3
NCT03348241 Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study Status COMPLETED Phase PHASE2
NCT03344068 Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE2/PHASE3